Fountain Therapeutics Closes $6 Million Series A-1 Financing
Closing brings total Series A financing sum to $11 million Funds to support expansion of team, technology platform and in vivo preclinical drug testing SAN FRANCISCO, May 19, 2020 (GLOBE NEWSWIRE) — Fountain Therapeutics (“Fountain”), a biopharmaceutical company building a pipeline of therapeutics to treat age-related diseases by reversing cellular age, today announced the closing of a …
Fountain Therapeutics Closes $6 Million Series A-1 Financing Read More »